

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs. Among its major competitors, PTC Therapeutics is ranked in 1st place for NPS while Biogen is 2nd, and Athersys is 3rd.Their current market cap is $3.27B
PTC Therapeutics's Net Promoter Score (NPS) is a 100 with 100% Promoters, 0% Passives, and 0% Detractors. Net Promoter Score tracks whether PTC Therapeutics's customers would recommend using the product based on a scale of -100 to 100.
| 100% | Promoters |
|---|---|
| 0% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Oct 2022 100 | Oct 2022 | 100 |
PTC Therapeutics is ranked first for NPS among its competitors. Biogen and Dicerna Pharmaceuticals come in second and third, with MyoKardia coming in at #4. Among those competitors, it is the third most valued company behind Biogen.
![]() PTC Therapeutics | ![]() Biogen | ![]() MyoKardia | ![]() Dicerna Pharmaceuticals | |
| Global Ranking | #- | #388 | #- | #- |
| NPS | 100 | 21 | - | - |
| Social Sentiment Calculated by analyzing social media and other online mentions | - | Neutral | Neutral | - |
| Valuation Updated every 24 hours for public companies | $3.27B | $42.46B | $11.99B | $2.99B |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Compared to its competitors, PTC Therapeutics's NPS is rated right above Biogen.
| COMPANY | NPS Score | |
|---|---|---|
![]() | PTC Therapeutics | 100 |
![]() | Biogen | 21 |
![]() | Dicerna Pharmaceuticals | N/A |
![]() | MyoKardia | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | Xencor | N/A |
PTC Therapeutics has an overall Product Quality score of 5 out of 5 stars rated by its users and customers.
Sign Up to unlock PTC Therapeutics' overall Product Quality score rated by its users and customers.
PTC Therapeutics’s product quality score is a 5 out of 5 as rated by its users and customers.
Compared to its competitors, PTC Therapeutics's Product Quality score is rated right above Biogen.
| COMPANY | Product Quality Score | |
|---|---|---|
![]() | PTC Therapeutics | 5/5 |
![]() | Biogen | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Dicerna Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | Xencor | N/A |
PTC Therapeutics has a value for money and ROI score of 1.5 out of 5 stars rated by its users and customers.
Sign Up to unlock PTC Therapeutics' overall ROI score rated by its users and customers.
Compared to its competitors, PTC Therapeutics's ROI score is rated right above Dicerna Pharmaceuticals, and is preceded by Biogen.
| COMPANY | Pricing Score | |
|---|---|---|
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | PTC Therapeutics | 1.5/5 |
![]() | Dicerna Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | Xencor | N/A |
PTC Therapeutics has an overall Customer Satisfaction score of 100 rated by its users and customers.
Sign Up to see the full customer demographics data and the people that answered "How would you rate your overall satisfaction with the service you received?"
Customer Satisfaction Score (also known as CSAT), is a metric used to quantify how satisfied customers are with a company or brand’s products and services. The Customer Satisfaction Score is based on customers response to the question: “How would you rate your overall satisfaction with the service you received?” The score is calculated using the formula: (The total number answer of “Very Satisfied” and “Satisfied”) ÷ (The total response) x100, and it is generally displayed in percentages. Some of the main benefits of the CSAT for businesses are tracking retention, identifying happy customers and growing relationships, and gaining repeat business to build a sustainable brand.
Compared to its competitors, PTC Therapeutics's Customer Satisfaction score is rated right above Biogen.
| COMPANY | Customer Satisfaction (CSAT) Score | |
|---|---|---|
![]() | PTC Therapeutics | 100% |
![]() | Biogen | 78% |
![]() | Dicerna Pharmaceuticals | 0% |
![]() | MyoKardia | 0% |
![]() | Reata Pharmaceuticals | 0% |
![]() | Xencor | 0% |
PTC Therapeutics has an overall Customer Service score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock PTC Therapeutics' overall Customer Service score rated by its users and customers.
100 Corporate Court, South Plainfield, NJ
http://www.ptcbio.com
9082227231
Compared to its competitors, PTC Therapeutics's Customer Service score is rated right above MyoKardia.
| COMPANY | Customer Service Score | |
|---|---|---|
![]() | PTC Therapeutics | 4/5 |
![]() | MyoKardia | 4/5 |
![]() | Biogen | 3.8/5 |
![]() | Dicerna Pharmaceuticals | N/A |
![]() | Reata Pharmaceuticals | N/A |
![]() | Xencor | N/A |
PTC Therapeutics has a 4.4/5 stars for its overall company culture rated by their employees

PTC Therapeutics scored a 100 for Net Promoter Score and a 25 for Employee Net Promoter Score. NPS gauges how likely a customer of PTC Therapeutics would recommend the brand to a friend. ENPS measures how likely PTC Therapeutics employees would recommend working at PTC Therapeutics to a friend.
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
| 50% | Promoters |
|---|---|
| 25% | Passive |
| 25% | Detractors |